We call that nasal cycling
Most of the guidance available comes from understanding each medication's individual cardiovascular profile and applying general pharmacological principles
Potential Risks and Complications Weight loss and improved blood sugar control come with some potential risks and complications
China: Demand for GLP-1 companion products in China is projected to grow at around an 11.7% CAGR through 2036, supported by rapid expansion of domestic GLP-1 user base for weight management, and formulation technologies, and growing focus on high-quality and science-backed companion products for muscle preservation and GI side-effect management
2024 10-k (from PDF p.7) Many of our compounded drugs are produced by our Pharmacies or Outsourcing Facility, MedisourceRx, and the promotion and advertising of these compounded drugs is subject to FDA regulation. 2025 10-k (from PDF p.11, emphasis PSM's) "FDA regulations relating to the advertising and promotion of prescription and over-the-counter drugs, including prescription compounded drugs , also require that promotional materials for prescription drugs not be false or misleading
Bring your medical history, list of medications, and your weight loss goals
